Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma - Concepedia

Concepedia

Publication | Closed Access

Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

596

Citations

16

References

2017

Year

Esma Saâda-Bouzid, Cécile Defaucheux, Andy Karabajakian, Virginia Palomar Coloma, Vincent Servois, Xavier Paolettí, Caroline Even, Jérôme Fayette, J. Guigay, Delphine Loirat,

Annals of Oncology

OncologyNeoadjuvant TherapyAnti-pd-1/pd-l1 TherapyImmune Checkpoint InhibitorHead And Neck CancerCancer TreatmentNeck OncologyMedicineRadiation Oncology

References

	Year	Citations

Page 1

Page 1